Variant report

Variant	nsv964059
Chromosome Location	chr4:69962051-69983787
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69981638-69981898	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69968302-69968701	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:69960997-69962638	HepG2	liver:	n/a	n/a
4	ARID3A	chr4:69964127-69964803	HepG2	liver:	n/a	n/a
5	BCL3	chr4:69960907-69962340	A549	lung:	n/a	n/a
6	BCL3	chr4:69961801-69962281	A549	lung:	n/a	n/a
7	CEBPB	chr4:69968429-69968717	HepG2	liver:	n/a	n/a
8	CEBPB	chr4:69980567-69980672	HepG2	liver:	n/a	n/a
9	CEBPB	chr4:69962103-69962398	HepG2	liver:	n/a	n/a
10	CEBPB	chr4:69968322-69968816	HepG2	liver:	n/a	n/a
11	CEBPB	chr4:69968440-69968803	HepG2	liver:	n/a	n/a
12	CEBPB	chr4:69964211-69964793	A549	lung:	n/a	chr4:69964654-69964665 chr4:69964655-69964666 chr4:69964654-69964667
13	CEBPB	chr4:69961749-69962164	A549	lung:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
14	CEBPB	chr4:69961654-69962398	A549	lung:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
15	CEBPB	chr4:69961795-69962072	HepG2	liver:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
16	CEBPB	chr4:69962157-69962338	HepG2	liver:	n/a	n/a
17	CEBPB	chr4:69964189-69964841	HepG2	liver:	n/a	chr4:69964654-69964665 chr4:69964655-69964666 chr4:69964654-69964667
18	CEBPB	chr4:69961802-69962387	A549	lung:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
19	CEBPB	chr4:69964210-69964437	HepG2	liver:	n/a	n/a
20	CEBPB	chr4:69961787-69962551	HepG2	liver:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
21	CEBPB	chr4:69968407-69968710	HepG2	liver:	n/a	n/a
22	CEBPB	chr4:69964243-69964585	HepG2	liver:	n/a	n/a
23	CREB1	chr4:69964151-69964530	HepG2	liver:	n/a	n/a
24	CTCF	chr4:69973871-69973986	GM10248	blood:	n/a	n/a
25	CTCF	chr4:69976680-69976830	GM06990	blood:	n/a	n/a
26	EP300	chr4:69963986-69964883	HepG2	liver:	n/a	chr4:69964434-69964444 chr4:69964222-69964229
27	EP300	chr4:69960670-69962557	A549	lung:	n/a	chr4:69962195-69962209 chr4:69961953-69961967
28	EP300	chr4:69961757-69962503	HepG2	liver:	n/a	chr4:69962195-69962209 chr4:69961953-69961967
29	EP300	chr4:69979061-69979105	K562	blood:	n/a	n/a
30	EP300	chr4:69963999-69964634	A549	lung:	n/a	chr4:69964434-69964444 chr4:69964222-69964229
31	EP300	chr4:69981467-69981988	HepG2	liver:	n/a	n/a
32	EP300	chr4:69968242-69968893	HepG2	liver:	n/a	chr4:69968261-69968275
33	EP300	chr4:69964060-69964689	A549	lung:	n/a	chr4:69964434-69964444 chr4:69964222-69964229
34	EP300	chr4:69961774-69962504	HepG2	liver:	n/a	chr4:69962195-69962209 chr4:69961953-69961967
35	EP300	chr4:69968446-69968702	HepG2	liver:	n/a	n/a
36	EP300	chr4:69964147-69964651	HepG2	liver:	n/a	chr4:69964434-69964444 chr4:69964222-69964229
37	EP300	chr4:69968279-69968852	HepG2	liver:	n/a	n/a
38	EP300	chr4:69961883-69962295	HepG2	liver:	n/a	chr4:69962195-69962209 chr4:69961953-69961967
39	EP300	chr4:69964115-69964688	HepG2	liver:	n/a	chr4:69964434-69964444 chr4:69964222-69964229
40	EP300	chr4:69961699-69962416	A549	lung:	n/a	chr4:69962195-69962209 chr4:69961953-69961967
41	FOS	chr4:69964209-69964677	MCF10A-Er-Src	breast:	n/a	n/a
42	FOS	chr4:69960914-69962258	MCF10A-Er-Src	breast:	n/a	n/a
43	FOS	chr4:69970506-69970695	MCF10A-Er-Src	breast:	n/a	n/a
44	FOS	chr4:69964226-69964689	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr4:69960975-69962225	MCF10A-Er-Src	breast:	n/a	n/a
46	FOS	chr4:69961775-69962178	MCF10A-Er-Src	breast:	n/a	n/a
47	FOS	chr4:69970447-69970653	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr4:69970465-69970700	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr4:69964146-69964787	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr4:69961822-69962132	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69962676-69962726	SK-N-MC	brain:	n/a
2	chr4:69962676-69962726	HCF	heart:	n/a
3	chr4:69962676-69962726	NHDF-neo	bronchial:	n/a
4	chr4:69976406-69976456	HEK293	kidney:	embryo
5	chr4:69962676-69962726	HCPEpiC	choroid plexus:	n/a
6	chr4:69976406-69976456	SAEC	small airway:	n/a
7	chr4:69976406-69976456	T-47D	breast:	n/a
8	chr4:69976406-69976456	Hela-S3	cervix:	n/a
9	chr4:69962676-69962726	ovcar-3	ovarian:	n/a
10	chr4:69976406-69976456	HCT-116	colon:	n/a
11	chr4:69976406-69976456	AoSMC	blood vessel:	n/a
12	chr4:69962676-69962726	HRCEpiC	kidney:	n/a
13	chr4:69962676-69962726	HUVEC	blood vessel:	n/a
14	chr4:69962676-69962726	HPAEpiC	pulmonary alveolar:	n/a
15	chr4:69976406-69976456	HCF	heart:	n/a
16	chr4:69976406-69976456	ECC-1	luminal epithelium:	n/a
17	chr4:69976406-69976456	HepG2	liver:	n/a
18	chr4:69962676-69962726	PFSK-1	brain:	n/a
19	chr4:69976406-69976456	NB4	blood:	n/a
20	chr4:69976406-69976456	GM12891	blood:	n/a
21	chr4:69962676-69962726	SK-N-SH	brain:	n/a
22	chr4:69962676-69962726	Hela-S3	cervix:	n/a
23	chr4:69962676-69962726	SAEC	small airway:	n/a
24	chr4:69962676-69962726	SKMC	muscle:	n/a
25	chr4:69976406-69976456	Hepatocyte	liver:	n/a
26	chr4:69962676-69962726	HNPCEpiC	eye:	n/a
27	chr4:69962676-69962726	K562	blood:	n/a
28	chr4:69962676-69962726	ProgFib	skin:	n/a
29	chr4:69962676-69962726	HRE	kidney:	n/a
30	chr4:69976406-69976456	PFSK-1	brain:	n/a
31	chr4:69976406-69976456	CMK	blood:	n/a
32	chr4:69962676-69962726	GM19239	blood:	n/a
33	chr4:69976406-69976456	K562	blood:	n/a
34	chr4:69976406-69976456	HAEpiC	amniotic membrane:	n/a
35	chr4:69962676-69962726	LNCaP	prostate:	n/a
36	chr4:69976406-69976456	HNPCEpiC	eye:	n/a
37	chr4:69976406-69976456	HRPEpiC	eye:	n/a
38	chr4:69962676-69962726	A549	lung:	n/a
39	chr4:69962676-69962726	AG09309	skin:	n/a
40	chr4:69962676-69962726	BJ	skin:	n/a
41	chr4:69976406-69976456	GM06990	blood:	n/a
42	chr4:69976406-69976456	NHDF-neo	bronchial:	n/a
43	chr4:69962676-69962726	HCT-116	colon:	n/a
44	chr4:69976406-69976456	HUVEC	blood vessel:	n/a
45	chr4:69976406-69976456	GM19239	blood:	n/a
46	chr4:69962676-69962726	AG10803	skin:	n/a
47	chr4:69962676-69962726	GM12892	blood:	n/a
48	chr4:69976406-69976456	AG10803	skin:	n/a
49	chr4:69976406-69976456	HRCEpiC	kidney:	n/a
50	chr4:69976406-69976456	PANC-1	pancreas:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:69964055..69967936-chr4:69969110..69971498,3	K562	blood:
2	chr4:69964055..69967936-chr4:69969110..69971498,3	K562	blood:
3	chr4:69981403..69984275-chr4:69989733..69991990,2	K562	blood:

Variant related genes	Relation type
UGT2B7	TF binding region
UGT2B7	CpG island
ENSG00000251284	chromatin interactions

Extended variants
information (count: 958 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:958 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7668258	chr4:69962078-69962079	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs563001412	chr4:69962097-69962098	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs73823859	chr4:69962101-69962102	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs545410639	chr4:69962104-69962105	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs7668282	chr4:69962114-69962115	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs116379338	chr4:69962120-69962121	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs150638622	chr4:69962140-69962141	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs560884549	chr4:69962160-69962161	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs529910226	chr4:69962228-69962229	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs369109329	chr4:69962231-69962232	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs375784186	chr4:69962234-69962235	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs111878373	chr4:69962237-69962238	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs201700247	chr4:69962310-69962311	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs200799009	chr4:69962312-69962313	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs202055250	chr4:69962346-69962347	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs58632287	chr4:69962360-69962361	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs569411321	chr4:69962362-69962363	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs373225477	chr4:69962373-69962374	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs61361928	chr4:69962375-69962376	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs148671766	chr4:69962383-69962384	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs376374784	chr4:69962398-69962399	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs201563351	chr4:69962401-69962402	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs142158304	chr4:69962404-69962405	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs147538491	chr4:69962408-69962409	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs144693330	chr4:69962420-69962421	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs373587868	chr4:69962447-69962448	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs151180306	chr4:69962448-69962449	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs12233719	chr4:69962449-69962450	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs61154511	chr4:69962452-69962453	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs376802547	chr4:69962458-69962459	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs371114623	chr4:69962459-69962460	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs567705679	chr4:69962472-69962473	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs368905272	chr4:69962476-69962477	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs373528265	chr4:69962477-69962478	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs377489223	chr4:69962502-69962503	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs370956653	chr4:69962511-69962512	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs373751680	chr4:69962519-69962520	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs367597912	chr4:69962546-69962547	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs370517827	chr4:69962550-69962551	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs140153012	chr4:69962559-69962560	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs373954369	chr4:69962572-69962573	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs57811242	chr4:69962589-69962590	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs28365063	chr4:69962610-69962611	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs35893826	chr4:69962619-69962620	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs368476298	chr4:69962648-69962649	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs267600220	chr4:69962649-69962650	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs545544033	chr4:69962659-69962660	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs147120761	chr4:69962676-69962677	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs372412977	chr4:69962691-69962692	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs202168877	chr4:69962727-69962728	Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:96 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69959600-69980000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr4:69960200-69962600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
3	chr4:69960400-69962200	Enhancers	Fetal Intestine Large	intestine
4	chr4:69960400-69962400	Enhancers	NHEK	skin
5	chr4:69960800-69962200	Enhancers	Fetal Intestine Small	intestine
6	chr4:69960800-69962400	Enhancers	HUVEC	blood vessel
7	chr4:69960800-69962600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr4:69960800-69962600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr4:69961000-69962200	Enhancers	Rectal Mucosa Donor 31	rectum
10	chr4:69961000-69962200	Enhancers	Hela-S3	cervix
11	chr4:69961000-69962600	Enhancers	HMEC	breast
12	chr4:69961200-69962200	Weak transcription	Pancreas	Pancrea
13	chr4:69961600-69962200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
14	chr4:69961600-69962400	Flanking Active TSS	A549	lung
15	chr4:69961600-69962800	Enhancers	Stomach Mucosa	stomach
16	chr4:69961800-69962200	Enhancers	Liver	Liver
17	chr4:69961800-69962200	Weak transcription	Duodenum Mucosa	Duodenum
18	chr4:69961800-69962400	Enhancers	Pancreatic Islets	Pancreatic Islet
19	chr4:69962000-69962400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr4:69962000-69962600	Enhancers	Muscle Satellite Cultured Cells	--
21	chr4:69962000-69962800	Flanking Active TSS	HepG2	liver
22	chr4:69962200-69962400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr4:69962200-69962400	Flanking Active TSS	Fetal Intestine Small	intestine
24	chr4:69962200-69962400	Enhancers	Pancreas	Pancrea
25	chr4:69962200-69962400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
26	chr4:69962200-69962600	Flanking Active TSS	Fetal Intestine Large	intestine
27	chr4:69962200-69963000	Active TSS	Duodenum Mucosa	Duodenum
28	chr4:69962200-69966600	Active TSS	Liver	Liver
29	chr4:69962400-69962600	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr4:69962400-69963000	Enhancers	A549	lung
31	chr4:69962400-69963200	Enhancers	iPS-18 Cell Line	embryonic stem cell
32	chr4:69962400-69963200	Active TSS	Fetal Intestine Small	intestine
33	chr4:69962600-69962800	Weak transcription	Rectal Mucosa Donor 29	rectum
34	chr4:69962600-69963000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr4:69962600-69963400	Enhancers	Fetal Intestine Large	intestine
36	chr4:69962600-69970400	Weak transcription	Rectal Mucosa Donor 31	rectum
37	chr4:69962800-69963000	Enhancers	Rectal Mucosa Donor 29	rectum
38	chr4:69962800-69964400	Weak transcription	Stomach Mucosa	stomach
39	chr4:69962800-69966400	Enhancers	HepG2	liver
40	chr4:69963000-69964400	Weak transcription	A549	lung
41	chr4:69963000-69964600	Weak transcription	Rectal Mucosa Donor 29	rectum
42	chr4:69963000-69968000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr4:69963000-69982000	Weak transcription	Duodenum Mucosa	Duodenum
44	chr4:69963200-69964000	Weak transcription	Fetal Intestine Small	intestine
45	chr4:69963400-69970400	Weak transcription	Fetal Intestine Large	intestine
46	chr4:69964000-69964400	Enhancers	Fetal Intestine Small	intestine
47	chr4:69964400-69964600	Enhancers	Stomach Mucosa	stomach
48	chr4:69964400-69964600	Enhancers	A549	lung
49	chr4:69964400-69969800	Weak transcription	Fetal Intestine Small	intestine
50	chr4:69964600-69965400	Enhancers	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links